Analyzing the Latest Data for Gonadotropin-Releasing Hormone Agonists and Antagonists in Prostate Cancer: What Does This Mean for the Patient?

Analyzing the Latest Data for Gonadotropin-Releasing Hormone Agonists and Antagonists in Prostate Cancer: What Does This Mean for the Patient?

The goal of this activity is for learners to be better able to analyze the latest data for gonadotropin-releasing hormone (GnRH) agonists and antagonists in prostate cancer and understand their implications for clinical practice.

  • Provider:Medscape, LLC
  • Activity Link: https://www.medscape.org/viewarticle/1000411
  • Start Date: 2024-03-15 05:00:00
  • End Date: 2024-03-15 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
  • MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: Source: Accord Healthcare Ltd. - Amount: 153697.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Medical Oncology
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.